Perrigo to Buy Héra for $2.1 Billion, Furthering Nonprescription Focus

https://images.wsj.net/im-397524/medium


A Perrigo facility in Israel. Chief Executive Murray Kessler called the purchase of Héra ‘a trade for what was volatile and declining earnings to growing extremely high-quality earnings.’

Photo: amir cohen/Reuters

This post was originally published on Wall Street Journal

Share:

Futurist Eric Fry says it will be a “Summer of Surge” for these three stocks

One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.

Watch now…

Latest News

Daily News on Investing, Personal Finance, Markets, and more!

Financial News

Financial News

Daily News on Investing, Personal Finance, Markets, and more!